EVALUATION OF URGOCLEAN AG, A NEW ANTIMICROBIAL DRESSING WITH CLEANING ACTION, ACROSS A RANGE OF WOUNDS WITHIN AN INTEGRATED TRUST
INTRODUCTION When new dressings become available it is always the ideal opportunity to appraise the efficacy within different wound types and patient groups that it has been recommended for. To ensure we captured varied wound types across the trust our evaluation of UrgoClean Ag was conducted within both the acute and primary care settings. The areas involved consisted of: • learning disabilities • podiatry • GP surgeries • Hospital Wards • Out Patient Departments • Nursing Homes • Community Clinics UrgoClean Ag is a poly-absorbent fibre dressing with silver which provides a combined action: • the poly-absorbent fibres trap and bind wound debris (such as: slough, exudate and biofilm) away from the wound bed • the TLC-Ag* healing matrix creates a moist wound healing environment whilst ensuring a sustained release of silver to the wound bed plus provision of a pain-free, atraumatic removal
METHOD The clinical specialist worked with each organisation to educate and support standardisation for the completion of the evaluation tool and the signs of a bacterial imbalance. The wound specifics, past medical history and the risk of infection parameters were captured using a bespoke data collection too.
The healthcare professionals involved were TVNs, a Nutrition Nurse, Podiatrists, Practice Nurses and Staff nurses who collected the data which was then reviewed by the clinical specialist to ensure there were no omissions. At each dressing change it was documented within the data capture tool whether there was a reduction in any of these signs of infection seen to monitor the speed of impact that UrgoClean Ag had on the wound. The wounds types included: • post-operative wound sites • leg ulcers • diabetic foot ulceration • trauma wounds • a gastrostomy stoma site
RESULTS 12 patient’s data was captured and all showed a clear reduction in the clinical signs and symptoms of infection whilst using UrgoClean Ag. The speed of impact varied between the individuals as would be expected due to their varied comorbidities and wound types, however, it was recorded that all patients had a visible bacterial load improvement at the first dressing change.
DISCUSSION AND CONCLUSION It is essential that healthcare professionals identify the clinical signs and symptoms of a wound infection and have the knowledge to treat in a timely way with an appropriate dressing. This will impact on the patient’s quality of life, prevent further wound complications and get them back onto a normal wound healing trajectory. Within these case studies it has been demonstrated that UrgoClean Ag was appropriately selected for wounds with an increased bacterial load allowing the effective removal of these barriers to expedite wound healing progression.